160 related articles for article (PubMed ID: 3155318)
21. Comparison of antianginal efficacy of nifedipine and isosorbide dinitrate in chronic stable angina: a long-term, randomized, double-blind, crossover study.
Liang CS; Coplin B; Wellington K
Am J Cardiol; 1985 May; 55(12):9E-14E. PubMed ID: 4003286
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of nicardipine in angina pectoris.
Thomas MG; Sander GE; Given MB; Quiroz AC; Roffidal LE; Giles TD
J Clin Pharmacol; 1990 Jan; 30(1):24-8. PubMed ID: 2406298
[TBL] [Abstract][Full Text] [Related]
23. [Comparative evaluation using an ergometric test of the efficacy of the 3 major calcium antagonists on exertion stable angina].
Papa M; Acanfora D; Artiaco D; Santangelo L; Covelluzzi F; De Rosa ML; Cicatiello M; De Caprio L; Rengo F
G Ital Cardiol; 1987 Apr; 17(4):344-50. PubMed ID: 3653591
[TBL] [Abstract][Full Text] [Related]
24. [The efficacy and safety of slow-release nicardipine vs nifedipine in angina].
Villanova C; Maddalena F; Rocco CG
Minerva Cardioangiol; 1994 Dec; 42(12):583-9. PubMed ID: 7753427
[TBL] [Abstract][Full Text] [Related]
25. Double-blind, randomized comparative study of the antihypertensive effect of nicardipine slow-release and nifedipine slow-release in hypertensive patients with coronary heart disease.
Maetzel FK; Teufel WE; Griebel A; Glocke MH
Cardiovasc Drugs Ther; 1991 Jun; 5(3):647-54. PubMed ID: 1878335
[TBL] [Abstract][Full Text] [Related]
26. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
[TBL] [Abstract][Full Text] [Related]
27. Comparative study of the effect of nifedipine versus diltiazem on exercise performance, serum propranolol levels, and ST-segment abnormalities in patients with chronic stable angina taking propranolol.
Robinson K; Krikler S; Krikler DM
Am J Cardiol; 1989 Sep; 64(11):27F-30F. PubMed ID: 2782269
[TBL] [Abstract][Full Text] [Related]
28. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
[TBL] [Abstract][Full Text] [Related]
29. Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina.
Khurmi NS; Bowles MJ; Bala Subramanian V; Raftery EB
J Am Coll Cardiol; 1984 Nov; 4(5):908-17. PubMed ID: 6386933
[TBL] [Abstract][Full Text] [Related]
30. An overview of the safety and efficacy of nicardipine in clinical trials.
Agre K
Am J Cardiol; 1987 Jun; 59(17):31J-35J. PubMed ID: 3300239
[TBL] [Abstract][Full Text] [Related]
31. Comparison of nicardipine and propranolol for chronic stable angina pectoris.
McGill D; McKenzie W; McCredie M
Am J Cardiol; 1986 Jan; 57(1):39-43. PubMed ID: 3510524
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the efficacy of nicardipine, a new calcium channel blocker, with nifedipine in the treatment of mild to moderate essential hypertension.
Armstrong C; Garnham J; Blackwood R
Postgrad Med J; 1987 Jun; 63(740):463-6. PubMed ID: 3432173
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina.
Meyer TE; Adnams C; Commerford P
Cardiovasc Drugs Ther; 1993 Dec; 7(6):909-13. PubMed ID: 8011570
[TBL] [Abstract][Full Text] [Related]
34. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
35. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
[TBL] [Abstract][Full Text] [Related]
36. A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina.
Akhras F; Chambers J; Jefferies S; Jackson G
Int J Cardiol; 1989 Aug; 24(2):191-6. PubMed ID: 2504673
[TBL] [Abstract][Full Text] [Related]
37. Nicardipine for angina pectoris at rest and coronary arterial spasm.
Gelman JS; Feldman RL; Scott E; Pepine CJ
Am J Cardiol; 1985 Aug; 56(4):232-6. PubMed ID: 3927691
[TBL] [Abstract][Full Text] [Related]
38. Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise.
Higginbotham MB; Morris KG; Coleman RE; Cobb FR
Am J Cardiol; 1986 May; 57(13):1022-8. PubMed ID: 3085464
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of nicardipine as monotherapy for chronic, stable angina.
Sklar J; Dennish GW; Glode J; Wyskoarko NP; Giles T; Freedman D; Buhite SG; Koretz SH; Roe RL
Am J Cardiol; 1989 May; 63(17):1203-7. PubMed ID: 2711990
[TBL] [Abstract][Full Text] [Related]
40. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
Frishman WH; Pepine CJ; Weiss RJ; Baiker WM
J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
